• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Colonic contribution to uremic solutes.肠道对尿毒症溶质的贡献。
J Am Soc Nephrol. 2011 Sep;22(9):1769-76. doi: 10.1681/ASN.2010121220. Epub 2011 Jul 22.
2
Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.HEMO 研究的结果表明,对甲酚硫酸盐和吲哚硫酸酯与心血管结局无关。
Kidney Int. 2017 Dec;92(6):1484-1492. doi: 10.1016/j.kint.2017.05.012. Epub 2017 Jul 21.
3
The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.等渗血液透析对尿毒症潴留溶质结合及清除的影响。
PLoS One. 2018 Feb 22;13(2):e0192770. doi: 10.1371/journal.pone.0192770. eCollection 2018.
4
Uremic solutes from colon microbes.肠道微生物来源的尿毒症溶质。
Kidney Int. 2012 May;81(10):949-954. doi: 10.1038/ki.2011.504. Epub 2012 Feb 8.
5
An Enlarged Profile of Uremic Solutes.尿毒症溶质的扩大概况。
PLoS One. 2015 Aug 28;10(8):e0135657. doi: 10.1371/journal.pone.0135657. eCollection 2015.
6
Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients.增加膳食纤维对血液透析患者结肠来源溶质血浆水平的影响。
Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1603-10. doi: 10.2215/CJN.00490114. Epub 2014 Aug 21.
7
Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production.用液相色谱/串联质谱法测定血液透析患者的蛋白结合型尿毒症毒素及其对内皮细胞 ROS 产生的影响。
Anal Bioanal Chem. 2012 Jun;403(7):1841-50. doi: 10.1007/s00216-012-5929-3. Epub 2012 Mar 25.
8
Uremic Solutes Produced by Colon Microbes.结肠微生物产生的尿毒症溶质。
Blood Purif. 2015;40(4):306-11. doi: 10.1159/000441578. Epub 2015 Nov 17.
9
Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.基于 CE-TOFMS 的代谢组学方法评价肠道微生物群对尿毒症溶质积累的影响。
Kidney Int. 2017 Sep;92(3):634-645. doi: 10.1016/j.kint.2017.02.011. Epub 2017 Apr 8.
10
Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial.在频繁血液透析网络每日试验中,增加透析频率和时间可使尿毒症溶质浓度降低有限。
Kidney Int. 2017 May;91(5):1186-1192. doi: 10.1016/j.kint.2016.11.002. Epub 2017 Jan 12.

引用本文的文献

1
The Non-Traditional Cardiovascular Culprits in Chronic Kidney Disease: Mineral Imbalance and Uremic Toxin Accumulation.慢性肾脏病中非传统的心血管致病因素:矿物质失衡与尿毒症毒素蓄积
Int J Mol Sci. 2025 Aug 17;26(16):7938. doi: 10.3390/ijms26167938.
2
Can Biomarkers Predict Kidney Function Recovery and Mortality in Patients with Critical COVID-19 and Acute Kidney Injury?生物标志物能否预测重症 COVID-19 和急性肾损伤患者的肾功能恢复及死亡率?
Diagnostics (Basel). 2025 Aug 5;15(15):1960. doi: 10.3390/diagnostics15151960.
3
Lacticaseibacillus rhamnosus attenuates uremic toxins in patients with nondialysis chronic kidney disease through the anti-inflammatory molecules.鼠李糖乳杆菌通过抗炎分子减轻非透析慢性肾病患者体内的尿毒症毒素。
Sci Rep. 2025 Jul 31;15(1):27990. doi: 10.1038/s41598-025-12768-z.
4
The role of the gut microbiota and its metabolites: a new predictor in diabetes and its complications.肠道微生物群及其代谢产物的作用:糖尿病及其并发症的新预测指标。
Eur J Med Res. 2025 Jul 9;30(1):601. doi: 10.1186/s40001-025-02824-9.
5
Murine maternal microbiome modifies adverse effects of protein undernutrition on offspring neurobehaviour.小鼠母体微生物群改变蛋白质营养不良对后代神经行为的不利影响。
Nat Microbiol. 2025 Jun 13. doi: 10.1038/s41564-025-02022-7.
6
Multi-Omics Integration in Nephrology: Advances, Challenges, and Future Directions.肾脏病学中的多组学整合:进展、挑战与未来方向
Semin Nephrol. 2024 Nov;44(6):151584. doi: 10.1016/j.semnephrol.2025.151584. Epub 2025 Apr 11.
7
Metabolomics to Identify Unclassified Uremic Toxins: A Comprehensive Literature Review.代谢组学用于鉴定未分类的尿毒症毒素:一项全面的文献综述。
Kidney Med. 2024 Dec 26;7(3):100955. doi: 10.1016/j.xkme.2024.100955. eCollection 2025 Mar.
8
Novel Protective Role for Gut Microbiota-derived Metabolite PAGln in Doxorubicin-induced Cardiotoxicity.肠道微生物群衍生代谢物PAGln在阿霉素诱导的心脏毒性中的新型保护作用
Cardiovasc Drugs Ther. 2025 Jan 14. doi: 10.1007/s10557-024-07665-y.
9
High interindividual variability of indoxyl sulfate production identified by an oral tryptophan challenge test.口服色氨酸激发试验确定硫酸吲哚酚生成存在高度个体间差异。
NPJ Biofilms Microbiomes. 2025 Jan 13;11(1):15. doi: 10.1038/s41522-025-00651-8.
10
The gut microbiome, chronic kidney disease, and sarcopenia.肠道微生物组、慢性肾脏病和肌肉减少症。
Cell Commun Signal. 2024 Nov 21;22(1):558. doi: 10.1186/s12964-024-01922-1.

本文引用的文献

1
Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry.应用液相色谱/串联质谱法对口服吸附剂 AST-120 的作用进行代谢组学搜索,以寻找尿毒症毒素作为其作用的指标。
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Nov 1;878(29):2997-3002. doi: 10.1016/j.jchromb.2010.09.006. Epub 2010 Sep 15.
2
Indoxyl sulfate is a nephro-vascular toxin.硫酸吲哚酚是一种肾血管毒素。
J Ren Nutr. 2010 Sep;20(5 Suppl):S2-6. doi: 10.1053/j.jrn.2010.05.002.
3
Metabolite profiling identifies markers of uremia.代谢组学分析鉴定出尿毒症的标志物。
J Am Soc Nephrol. 2010 Jun;21(6):1041-1051. doi: 10.1681/ASN.2009111132. Epub 2010 Apr 8.
4
The gut: the forgotten organ in uremia?肠道:尿毒症中被遗忘的器官?
Blood Purif. 2010;29(2):130-6. doi: 10.1159/000245639. Epub 2010 Jan 8.
5
Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research.基于质谱的代谢组学:局限性及对未来进展的建议,特别关注营养研究
Metabolomics. 2009 Dec;5(4):435-458. doi: 10.1007/s11306-009-0168-0. Epub 2009 Jun 12.
6
Methylamine clearance by haemodialysis is low.血液透析清除甲胺的能力较低。
Nephrol Dial Transplant. 2010 May;25(5):1608-13. doi: 10.1093/ndt/gfp629. Epub 2009 Dec 17.
7
Uremic toxins originating from colonic microbial metabolism.源自结肠微生物代谢的尿毒症毒素。
Kidney Int Suppl. 2009 Dec(114):S12-9. doi: 10.1038/ki.2009.402.
8
The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases.MetaCyc 数据库包含代谢途径和酶,以及 BioCyc 集合的途径/基因组数据库。
Nucleic Acids Res. 2010 Jan;38(Database issue):D473-9. doi: 10.1093/nar/gkp875. Epub 2009 Oct 22.
9
Development and reproducibility of a novel high-performance liquid-chromatography monolithic column method for the detection and quantification of trans-indolyl-3-acryloylglycine in human urine.一种用于检测和定量人尿中反式吲哚-3-丙烯酰甘氨酸的新型高效液相色谱整体柱方法的开发与重现性
Biomed Chromatogr. 2009 Oct;23(10):1108-15. doi: 10.1002/bmc.1231.
10
Effect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of protein-bound solutes: a pilot crossover trial.增加透析器传质面积系数和透析液流量对蛋白结合溶质清除率的影响:一项初步交叉试验
Am J Kidney Dis. 2009 Jun;53(6):1042-9. doi: 10.1053/j.ajkd.2009.01.265. Epub 2009 Apr 25.

肠道对尿毒症溶质的贡献。

Colonic contribution to uremic solutes.

机构信息

Vincent Coates Foundation Mass Spectrometry Laboratory, Stanford University, Stanford, California, USA.

出版信息

J Am Soc Nephrol. 2011 Sep;22(9):1769-76. doi: 10.1681/ASN.2010121220. Epub 2011 Jul 22.

DOI:10.1681/ASN.2010121220
PMID:21784895
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3171947/
Abstract

Microbes in the colon produce compounds, normally excreted by the kidneys, which are potential uremic toxins. Although p-cresol sulfate and indoxyl sulfate are well studied examples, few other compounds are known. Here, we compared plasma from hemodialysis patients with and without colons to identify and further characterize colon-derived uremic solutes. HPLC confirmed the colonic origin of p-cresol sulfate and indoxyl sulfate, but levels of hippurate, methylamine, and dimethylamine were not significantly lower in patients without colons. High-resolution mass spectrometry detected more than 1000 features in predialysis plasma samples. Hierarchical clustering based on these features clearly separated dialysis patients with and without colons. Compared with patients with colons, we identified more than 30 individual features in patients without colons that were either absent or present in lower concentration. Almost all of these features were more prominent in plasma from dialysis patients than normal subjects, suggesting that they represented uremic solutes. We used a panel of indole and phenyl standards to identify five colon-derived uremic solutes: α-phenylacetyl-l-glutamine, 5-hydroxyindole, indoxyl glucuronide, p-cresol sulfate, and indoxyl sulfate. However, compounds with accurate mass values matching most of the colon-derived solutes could not be found in standard metabolomic databases. These results suggest that colonic microbes may produce an important portion of uremic solutes, most of which remain unidentified.

摘要

结肠中的微生物会产生化合物,这些化合物通常会被肾脏排出,它们是潜在的尿毒症毒素。虽然对邻苯二酚硫酸盐和吲哚硫酸酯已有深入研究,但人们对其他化合物知之甚少。在这里,我们比较了有结肠和无结肠的血液透析患者的血浆,以鉴定和进一步描述源自结肠的尿毒症溶质。HPLC 证实了邻苯二酚硫酸盐和吲哚硫酸酯的结肠来源,但无结肠患者的马尿酸、甲胺和二甲胺水平并没有显著降低。高分辨率质谱检测到预透析血浆样本中存在 1000 多种特征。基于这些特征的层次聚类清楚地将有结肠和无结肠的透析患者区分开来。与有结肠的患者相比,我们在无结肠的患者中发现了 30 多种特征,这些特征要么不存在,要么存在浓度较低。几乎所有这些特征在无结肠的透析患者中比在正常受试者中更为突出,这表明它们代表尿毒症溶质。我们使用一组吲哚和苯标准品来鉴定五种源自结肠的尿毒症溶质:α-苯乙酰基-l-谷氨酰胺、5-羟基吲哚、吲哚基葡萄糖醛酸、邻苯二酚硫酸盐和吲哚硫酸酯。然而,在标准代谢组学数据库中无法找到与大多数源自结肠的溶质具有准确质量值的化合物。这些结果表明,结肠微生物可能会产生大量尿毒症溶质,其中大多数仍未被识别。